Pediatric Crohn's Disease in the Upper Gastrointestinal Tract: Clinical, Laboratory, Endoscopic, and Histopathological Analysis.

Also, a borderline significant change ( p = 0.05) was observed in patients on immunomodulators, as they had a higher incidence of normal (42.2%/30.6%) and non-specific (31.1%/16.7%) and a lower percentage of specific (26.7%/52.8%) findings on upper endoscopy.

also in 2,000 other papers